Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysis
Shuling Zhang, Yuan Tian, Jing Yu, Jie-Hui Zhang, Li Sun, Le‐Tian Huang, Jie-Tao Ma, Cheng‐Bo Han
Topics & Concepts
MedicineMeta-analysisImmunotherapyOncologyLung cancerNeoadjuvant therapyProgrammed cell death 1Internal medicineCancerPD-L1Breast cancerCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Research Studies